Skip to main content

Table 6 Summary of test results for patients with false negative results on the Well assay (n = 39)

From: Evaluation of a new point-of-care oral anti-HCV test for screening of hepatitis C virus infection

Subject IDWell oral anti-HCV assaySerum anti-HCV (Abbott assay) (S/Co)OraQuick anti-HCV assayeSerum anti-HCV (InTec assay)HCV RNA (IU/mL)Antiviral treatment
301391.08NA< 100no therapeutic indication
302151.43NA< 100no therapeutic indication
301861.5NA< 100no therapeutic indication
301402.13NA< 100no therapeutic indication
200312.53< 100no therapeutic indication
201222.9NA< 100PEG-IFN and ribavirin, SVR
200193.53< 100no therapeutic indication
301684.12NA< 100no therapeutic indication
302284.47NA< 100no therapeutic indication
200384.59< 100no therapeutic indication
301504.65NA< 100no therapeutic indication
201994.69NA< 100no therapeutic indication
301554.74NA< 100no therapeutic indication
302145.57NA< 100no therapeutic indication
300206.46< 100sofosbuvir/velpatasvir, SVR
301957.03< 100no therapeutic indication
303177.41NA+< 100sofosbuvir/daclatasvir, SVR
303217.8NA+< 100no therapeutic indication
201127.81NA< 100PEG-IFN and ribavirin, SVR
301088.2NA< 100PEG-IFN and ribavirin, SVR
302268.43NA< 100no therapeutic indication
302388.49NA< 100PEG-IFN and ribavirin, SVR
2001011.07+< 100sofosbuvir/velpatasvir, SVR
3025611.07NA+< 100PEG-IFN and ribavirin, SVR
3024511.97NA+< 100PEG-IFN and ribavirin, SVR
2005612.35NA< 100no therapeutic indication
3024112.35NA+< 100PEG-IFN and ribavirin, SVR
3016212.69NA+< 100no therapeutic indication
1028712.98NA+< 100sofosbuvir and ribavirin, SVR
1029413.09NA+< 100sofosbuvir and ribavirin, SVR
2009513.1NA+< 100PEG-IFN and ribavirin, SVR
3012813.42NA+< 100sofosbuvir and ribavirin, SVR
3025113.51NA+< 100PEG-IFN and ribavirin, SVR
2030113.61NA+< 100PEG-IFN and ribavirin, SVR
3024913.81NA+< 100PEG-IFN and ribavirin, SVR
2012514.87NA+< 100elbasvir/grazoprevir, SVR
3024615.25NA+< 100PEG-IFN and ribavirin, SVR
1002515.72++< 100no therapeutic indication
2014015.76NA+6.38E+ 05treatment naive
  1. Note: Subject ID were assigned according to the order in which subjects participated in the study. The ID consists of five digits, with the first digit representing the center. e7 of the 39 subjects with false-negative results were tested with OraQuick assay. NA Not applicable, PEG-IFN Pegylated-interferon, SVR Sustained virological response